Insulin glargine, recombinant Subcutaneous and Pertuzumab Intravenous
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Pertuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: pertuzumab
Brand name: Perjeta
Synonyms: Pertuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Pertzye
- Insulin glargine, recombinant Subcutaneous-Pexeva
- Insulin glargine, recombinant Subcutaneous-Pexidartinib
- Insulin glargine, recombinant Subcutaneous-Pexidartinib Hydrochloride
- Insulin glargine, recombinant Subcutaneous-Pfizerpen
- Insulin glargine, recombinant Subcutaneous-Pharaon Tea
- Pertuzumab Intravenous-Insulin glulisine
- Pertuzumab Intravenous-Insulin Glulisine (Cartridges and Pens)
- Pertuzumab Intravenous-Insulin Glulisine (Vials)
- Pertuzumab Intravenous-Insulin glulisine Subcutaneous
- Pertuzumab Intravenous-Insulin human inhaled Inhalation
- Pertuzumab Intravenous-Insulin human regular Injection